SEC Form 4 · accession 0001209191-16-124173
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pamela Reilly Contag
Director
Period of report
May 25, 2016
Accepted (ET)
May 27, 2016 · 8:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 25, 2016 | M | 17,895 | — | A | 17,895 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | May 25, 2016 | M | 17,895 | D | — | — | Common Stock | 17,895 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represented a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock, which settled upon the termination of the reporting person's service as a director as of the issuer's 2016 annual meeting of stockholders.
- F2The restricted stock units vested with respect to 7/12ths of the total shares on December 17, 2015, and with respect to 1/12th the of the total shares subject to the grant monthly thereafter.